The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
HIV prevention cost-effectiveness: a systematic review
Open accessAbstract
Background: After more than 25 years, public health programs have not been able to sufficiently reduce the number of new HIV infections. Over 7,000 people become infected with HIV every day. Lack of convincing evidence of cost-effectiveness (CE) may be one of the reasons why implementation of effective programs is not occurring at sufficient scale. This paper identifies, summarizes and critiques the CE literature related to HIV-prevention interventions in low- and middle-income countries during 2005-2008. Methods: Systematic identification of publications was conducted through several methods: electronic databases, internet search of international organizations and major funding/implementing agencies, and journal browsing. Inclusion criteria included: HIV prevention intervention, year for publication (2005-2008), setting (low- and middle-income countries), and CE estimation (empirical or modeling) using outcomes in terms of cost per HIV infection averted and/or cost per disability-adjusted life year (DALY) or quality-adjusted life year (QALY). Results: We found 21 distinct studies analyzing the CE of HIV-prevention interventions published in the past four years (2005-2008). Seventeen CE studies analyzed biomedical interventions; only a few dealt with behavioral and environmental/structural interventions. Sixteen studies focused on sub-Saharan Africa, and only a handful on Asia, Latin America and Eastern Europe. Many HIV-prevention interventions are very cost effective in absolute terms (using costs per DALY averted), and also in country-specific relative terms (in cost per DALY measured as percentage of GDP per capita). Conclusion: There are several types of interventions for which CE studies are still not available or insufficient, including surveillance, abstinence, school-based education, universal precautions, prevention for positives and most structural interventions. The sparse CE evidence available is not easily comparable; thus, not very useful for decision making. More than 25 years into the AIDS epidemic and billions of dollars of spending later, there is still much work to be done both on costs and effectiveness to adequately inform HIV prevention planning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Kirby, D. B., Laris, B. A., & Rolleri, L. A. (2007) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2006.11.143 · Cited by 915
Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence
Creese, A., Floyd, K., Alban, A., & Guinness, L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08595-1 · Cited by 394
Cited by
The Demand for, and Impact of, Learning HIV Status
Thornton, R. L. (2008) · American Economic Review · doi:10.1257/aer.98.5.1829 · Cited by 503
Degenhardt, L., Mathers, B., Vickerman, P., Rhodes, T., Latkin, C., & Hickman, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60742-8 · Cited by 423
Njeuhmeli, E., Forsythe, S., Reed, J., Opuni, M., Bollinger, L., Heard, N., Castor, D., Stover, J., Farley, T., Menon, V., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001132 · Cited by 318
Bell, B. T., Taylor, C., Paddock, D., & Bates, A. (2022) · British Journal of Educational Psychology · doi:10.1111/bjep.12449 · Cited by 43
Sherr, K., Ásbjörnsdóttir, K., Crocker, J., Coutinho, J., de Fatima Cuembelo, M., Tavede, E., Manaca, N., Ronen, K., Murgorgo, F., Barnabas, R., et al. (2019) · Implementation Science · doi:10.1186/s13012-019-0889-z · Cited by 33
Metadata
- Authors
- Galárraga, O., Colchero, M. A., Wamai, R. G., & Bertozzi, S. M.
- Venue
- BMC Public Health
- Published
- 2009-11
- Volume
- 9
- Issue
- S1
- Pages
- S5-S5
- ISSN
- 1471-2458 (ISSN-L)
- OpenAlex
- W2029480172
- Cited by
- 180
- References
- 4
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIV prevention cost-effectiveness: a systematic review. https://app.cochat.ai/papers/10.1186/1471-2458-9-s1-s5
- The paper
- Galárraga, O., Colchero, M. A., Wamai, R. G., & Bertozzi, S. M. (2009). HIV prevention cost-effectiveness: a systematic review. BMC Public Health. https://doi.org/10.1186/1471-2458-9-s1-s5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.